Lupus (systemic lupus erythematosus, SLE) is an autoimmune disease in which the body's immune system mistakenly attacks its own tissues, particularly affecting joints, skin, kidneys, and the nervous system.
Lupus (systemic lupus erythematosus, SLE) is an autoimmune disease in which the body's immune system mistakenly attacks its own tissues, particularly affecting joints, skin, kidneys, and the nervous system. The condition arises when B cells and T cells lose tolerance to self-antigens, producing damaging antibodies and inflammatory cytokines. Placental mesenchymal stem cells show promise because they release immunomodulatory factors—interleukins, soluble HLA-G, and exosomes containing regulatory microRNAs—that rebalance Th17 and regulatory T-cell populations. Early-stage clinical research (47 registered trials, 6 currently recruiting) suggests this approach may reduce disease activity scores and improve organ function in selected patients, though long-term remission rates remain under investigation.
| Cost indicativ · Bulgaria (UE) | €3,000–€8,000 |
|---|---|
| Gama costurilor pieței globale | €9,200–€23,000 (dvcstem.com) |
| Principalele tipuri de celule studiate | MSC de la membrana amniotică |
| Statutul aprobării | Investigațional |
| Studii înregistrate (ClinicalTrials.gov) | 47 · 6 recruiting now |
For the clinic's own description, see our partner clinic Stem Plus.
Registered trial data spans phase I safety through phase II efficacy work across global centres. Representative studies report disease activity index improvements in 60–75% of infused cohorts over 12 months, with renal histology stabilisation in 40–55% of lupus nephritis cases. Cytokine profiling shows durable reduction in pro-inflammatory markers (TNF-α, IL-6) persisting 6–9 months post-infusion. No completed phase III pivotal trial has yet reported, making this investigational rather than standard-of-care.
Depending on assessment, a Lupus (SLE) protocol may draw on:
Lupus stem-cell protocols in Sofia clinics typically range €4,500–7,500, reflecting multiple intravenous or intra-articular administrations (2–4 infusions over 6 months), imaging surveillance, and immunological monitoring. Regional variation reflects cell source (umbilical cord, bone marrow, or placental) and expansion methodology. Insurance rarely covers experimental protocols, and travel costs for international treatment add substantially to out-of-pocket expenses.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Lupus (SLE) cost-by-country breakdown, or compare the best countries for Lupus (SLE) →
Before booking, check safety & regulation, the recovery climate, dacă ai putea fi candidat, and which cell type fits Lupus (SLE).
FAQ complet Lupus (SLE) → · Defalcare costuri Lupus (SLE) →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: Sunt eu un candidat? · Ce tip de celulă? · Types of clinics & best countries · Calculator de costuri
Revizuit medical de echipa editorială a StemCellAtlas cu Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) ale clinicii partenere Stem Plus (Sofia), în funcție de orientările ISSCR, FDA și EMA. Educational information, not medical advice; figures indicative.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită